An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms

This is a 24-week, single-arm, open-label, virtual study evaluating the effects of Elix Cycle Balance and Elix Daily Harmony on uterine fibroid-related symptoms and quality of life in 42 participants. Participants will self-administer the investigational herbal supplements daily and complete validated questionnaires at scheduled timepoints to assess symptom severity and quality of life.

Trial Details

NCT ID
NCT07078682
Phase
NA
Sponsor
Zenchi, Inc.
Status
RECRUITING
Cancer Type
Uterine Cancer
Interventions
  • Elix Daily Harmony
Locations (sample)
  • Las Vegas, Nevada, United States|36.17497,-115.13722

Key Eligibility Criteria

  • Be female.
  • Be aged 20-45.
  • BMI 18.5 - 24.9 kg/m2
  • Self-reported prior diagnosis of uterine fibroids.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Uterine Cancer Trials on Trialify →